[HTML][HTML] Biomarkers for predicting the response to radiation-based neoadjuvant therapy in rectal cancer
Y Chen, B Yang, M Chen, Z Li, Z Liao - Frontiers in Bioscience …, 2022 - imrpress.com
Locally advanced rectal cancer (RC) is treated with neoadjuvant chemoradiotherapy (nCRT)
followed by radical surgery. Currently, organ-sparing approaches and/or “watch-and-wait” …
followed by radical surgery. Currently, organ-sparing approaches and/or “watch-and-wait” …
[HTML][HTML] Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study
J Liu, X Yu, X Huang, Q Lai, J Chen - Cancer Imaging, 2023 - Springer
Objective To investigate the role of preoperative body composition analysis for muscle and
adipose tissue distribution on long-term oncological outcomes in patients with middle and …
adipose tissue distribution on long-term oncological outcomes in patients with middle and …
Artificial intelligence measured 3D body composition to predict pathological response in rectal cancer patients
MY Wei, K Cao, W Hong, J Yeung, M Lee… - ANZ Journal of …, 2024 - Wiley Online Library
Background The treatment of locally advanced rectal cancer (LARC) is moving towards total
neoadjuvant therapy and potential organ preservation. Of particular interest are predictors of …
neoadjuvant therapy and potential organ preservation. Of particular interest are predictors of …
[PDF][PDF] The Relationship Between the Response to Neoadjuvant Chemoradiotherapy and Mesorectum Volume in Rectum Cancer Rektum Kanserinde Neoadjuvan …
RS Kerimoğlu, E Esen, M Saraçoğlu, İ Babalioglu… - jag.journalagent.com
Introduction: To investigate the relationship of changes in the mesorectum volume (MRV)
associated with neoadjuvant chemoradiotherapy (nCRT) with pathological and clinical …
associated with neoadjuvant chemoradiotherapy (nCRT) with pathological and clinical …